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Pietary Fish and n-3 Fatty Acid Intake and
ardiac Electrocardiographic Parameters in Humans
ariush Mozaffarian, MD, DRPH, FACC,*† Ronald J. Prineas, MD, PHD,‡
hyllis K. Stein, PHD,§ David S. Siscovick, MD, MPH
oston, Massachusetts; Winston-Salem, North Carolina; St. Louis, Missouri; and Seattle, Washington
OBJECTIVES We evaluated the association between dietary fish intake and several cardiac electrocardio-
graphic parameters in humans relevant to arrhythmic risk.
BACKGROUND Fish consumption may reduce the incidence of sudden death and atrial fibrillation, possibly
related to anti-arrhythmic effects.
METHODS In a population-based study of 5,096 men and women, we evaluated cross-sectional
associations between usual dietary fish intake and electrocardiographic measures of heart rate,
atrioventricular conduction (PR interval), ventricular repolarization (QT interval), and
ventricular conduction (QRS interval). Multivariate models were adjusted for age, gender,
race, education, smoking, body mass index, diabetes, coronary heart disease, physical activity,
and intakes of beef or pork, fried fish, fruits, vegetables, alcohol, and total calories.
RESULTS Consumption of tuna or other broiled or baked fish (comparing the highest to the lowest
category of intake) was associated with lower heart rate (3.2 beats/min, 95% confidence
interval [CI]  1.3 to 5.1; p trend 0.001), slower atrioventricular conduction (PR interval
7.2 ms, 95% CI  1.4 to 12.9; p trend  0.03), and substantially lower likelihood of
prolonged QT (relative risk 0.50, 95% CI 0.27 to 0.95; p trend 0.03). Tuna/other fish
intake was not associated with ventricular conduction (p  0.60). Findings were similar for
estimated intake of marine n-3 fatty acids: a 1 g/day higher intake was associated with 2.3
beats/min lower heart rate (95% CI  0.9 to 3.7), 7.6 ms longer PR interval (95% CI  3.3
to 11.9), and 46% lower likelihood of prolonged QT (relative risk  0.54, 95% CI  0.33 to
0.88).
CONCLUSIONS These findings in this large, population-based study suggest that dietary fish intake is
associated with cardiac electrophysiology in humans, including heart rate, atrioventricular
conduction, and ventricular repolarization, with potential implications for arrhythmic
risk. (J Am Coll Cardiol 2006;48:478–84) © 2006 by the American College of Cardiology
ublished by Elsevier Inc. doi:10.1016/j.jacc.2006.03.048Foundation
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catty fish intake is associated with lower risk of cardiac
rrhythmias including sudden death (1,2), arrhythmic cor-
nary heart disease (CHD) death (3), and atrial fibrillation
4). However, mechanisms underlying these relationships
re not well established. Experimental studies in isolated rat
yocytes, exercising dogs, and non-human primates suggest
hat fish oil has direct cardiac electrophysiologic effects
5,6). In dogs, infusion of fish oil slows the heart rate (HR),
lows atrioventricular conduction (the PR interval), and
ffects ventricular repolarization (the QT interval) (7).
ecause increased HR and an abnormal QT interval, as
efined by surface electrocardiogram, predict arrhythmic
vents in humans (8–12), these experimental studies pro-
ide plausible potential mechanisms that might, in part,
From the *Channing Laboratory, Department of Medicine, Brigham and Women’s
ospital and Harvard Medical School, and the †Departments of Epidemiology and
utrition, Harvard School of Public Health, Boston, Massachusetts; ‡Department of
ublic Health Sciences, Wake Forest University School of Medicine, Winston-
alem, North Carolina; §Heart Rate Variability Laboratory, Washington University
chool of Medicine, St. Louis, Missouri; and the Cardiovascular Health Research
nit, Departments of Medicine and Epidemiology, University of Washington,
eattle, Washington. The NHLBI, NIH, provided support for the research reported
n this article (K08-HL-075628; contracts N01-HC-85079 through N01-HC-
5086, N01-HC-35129, and N01-HC-15103). For a full list of CHS investigators
nd institutions, see “About CHS-Principal Investigators and Study Sites” at
ttp://chs-nhlbi.org.n
Manuscript received January 12, 2006; revised manuscript received March 17,
006, accepted March 22, 2006.xplain observed relationships between fish intake and
rrhythmic risk in humans. We have previously shown that
sh intake is associated with lower HR as determined by
hysical examination (13), and that fish oil supplementation
owers HR in randomized trials (14) (although doses in the
rials were generally higher than achieved by dietary fish
ntake). The impact of usual dietary fish intake on other
ardiac electrocardiographic (ECG) parameters in humans
s unclear. We investigated the associations between usual
onsumption of fish and marine n-3 fatty acids and ECG
easures among men and women enrolled in the Cardio-
ascular Health Study (CHS), a large, population-based
ohort study of risk factors for cardiovascular disease in
lder adults.
ETHODS
esign and population. We performed a cross-sectional
ohort analysis among participants in the CHS. The design
nd recruitment experiences have been described (15,16). In
989 to 1990, 5,201 men and women age 65 years were
andomly selected and enrolled from Medicare eligibility
ists in 4 U.S. communities. An additional 687 black
articipants recruited and enrolled in 1992 were not in-
luded in this analysis because a food frequency question-
aire was not administered to these participants at baseline.
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August 1, 2006:478–84 Fish Intake and ECG Parametersach center’s institutional review committee approved the
tudy, and all subjects gave informed consent. Participants
ompleted questionnaires on health status, medical history,
nd cardiovascular risk factors, and underwent standardized
hysical examination and laboratory evaluation (15–17).
fter excluding 2 individuals in whom an ECG was not
btained and 103 individuals with incomplete data on fish
onsumption, 5,096 participants were available for this
nalysis.
ietary assessment. Usual dietary intake was assessed
sing a picture-sort version of the National Cancer Institute
ood frequency questionnaire (18). Participants were asked
o indicate how often, on average, they had consumed
arious specified foods over the prior year, including ques-
ions on intake of tuna fish, other fish (broiled or baked),
nd fried fish or fish sandwiches (fish burgers). For each
ood, participants chose among 5 possible response catego-
ies ranging from4/year to 5/week. Intakes of these fish
eals were summed as previously described (13). In a subset
f 56 participants, plasma phospholipid levels of eicosapen-
aenoic acid (EPA) (20:5 n-3) and docosahexaenoic acid
DHA) (22:6 n-3) correlated with intake of tuna fish and
ther broiled or baked fish (r  0.55, p  0.001), but not
ried fish (r  0.04, p  0.78) (3). We focused on the
elations between consumption of tuna/other fish and ECG
easures, because these fish meals appeared to represent
ily fish containing n-3 fatty acids and have been associated
ith lower risk of arrhythmic events (3,4). Dietary intake of
PA  DHA was calculated from the questionnaire based
n estimated content in each seafood serving (3 to 5 oz) (19)
nd U.S. fisheries commercial landings data (20).
CG measures. A standardized resting 12-lead ECG was
btained on each participant (21). Electrocardiographic char-
cteristics, including HR and time intervals, were defined in a
entralized reading center using the NOVACODE classifica-
ion (22). Ventricular repolarization was evaluated using the
T index (QTI), which more completely corrects for differ-
nces in HR compared with other nomograms (23). Prolonged
T was defined as QTI 110 (i.e., QT interval exceeding by
10% the predicted QT interval for a given HR), a traditional
efinition based on the non-linear relationship between QTI
nd risk of sudden death (24). For primary QT interval
nalyses, we excluded individuals with QRS120 ms (bundle
Abbreviations and Acronyms
CHD  coronary heart disease
CHS  Cardiovascular Health Study
CI  confidence interval
DHA  docosahexaenoic acid
ECG  electrocardiographic
EPA  eicosapentaenoic acid
HR  heart rate
QTc  corrected QT interval
QTI  QT indexranch block; n 400). We also evaluated a modified QTI in ahich QTI was replaced with the JT index for individuals with
RS120 ms (25). We also evaluated a corrected QT interval
QTc) using Karjalainen’s nomogram (26), excluding individ-
als with QRS120 ms and also those with HRs outside the
omogram range (39 or 121 beats/min; n  23). We
valuated both a shortened QTc (400 ms) and a prolonged
Tc (440 ms), as both may confer increased risk of sudden
eath, compared with a normal QTc of 400 to 440 ms (11).
tatistical analysis. The associations between fish intake
nd ECG parameters were evaluated using linear regression
or continuous measures and logistic regression for binary
easures. Fish intakes were evaluated as indicator categor-
cal variables. Tests for trend were performed evaluating
ntake categories as ordinal variables. Associations between
ietary n-3 fatty acid intake and ECG measures were
valuated by fitting restricted natural cubic splines (27,28)
nd plotting the fitted smooth curve. This method uses
iecewise third-order polynomials at equally spaced quan-
iles to model the best non-linear fit of a relationship,
onstrained to be linear beyond the extreme knots and to be
verywhere twice continuously differentiable. Potential
hreshold effects were evaluated by adding a multiplicative
nteraction term (threshold indicator variable times contin-
ous variable), the significance of which was evaluated using
likelihood-ratio test. Not all ECG measures were obtain-
ble on every participant due to underlying rhythm, struc-
ural, or artifactual irregularities. Therefore, for each mea-
ure, individuals with missing values (1.3% to 5.9% of
articipants, depending on the measure) were excluded from
hat analysis. To minimize potential confounding, covari-
tes were included based on clinical relevance as factors that
ay influence both exposures and outcomes, previously
ublished associations, or associations with exposures/
utcomes in the current data set. The final model was
djusted for age, gender, race, education, smoking, body
ass index, diabetes mellitus, CHD, physical activity, and
ntakes of beef or pork, fruits, vegetables, fried fish, alcohol,
nd total calories. For parsimony in model construction,
ther covariates that did not materially alter the relations
etween fish consumption and the outcome measures were
xcluded from the final model, including enrollment site,
nnual income, treated hypertension, exercise intensity, use
f aspirin, beta-blockers, calcium-channel blockers, class 1A
r class III antiarrhythmics, tricyclic antidepressants, lipid-
owering medication, and estrogen, and estimated intake of
otal fat, saturated fat, linolenic acid, carbohydrates, protein,
ber, and wine. Few participants (3.7%) were taking fish oil
upplements, and adjustment for fish oil use or exclusion of
hese participants had little effect on results. Missing co-
ariate values (4% for dietary covariates; 1% for other
ovariates) were imputed using age, race, gender, diabetes,
nd prevalent cardiovascular disease; analyses using the
opulation median or excluding missing data were not
ppreciably different. Potential effect modification was as-
essed in pre-specified subgroups for treated hypertension
nd prevalent CHD using stratified analyses, the signifi-
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Fish Intake and ECG Parameters August 1, 2006:478–84ance of which was evaluated using likelihood-ratio testing
ith multiplicative interaction terms (exposure times covari-
te). All p values were 2-tailed (alpha  0.05). Analyses
ere performed using Stata 8.2 (Stata Corp., College
tation, Texas).
ESULTS
ivariate (unadjusted) associations between tuna/other fish
ntake and selected risk factors are shown (Table 1);
elationships with other participant characteristics in the
HS have been reported (3,4). Tuna/other fish consump-
ion was associated with slightly younger age, female gen-
er, higher education, less smoking, and higher body mass
ndex. Tuna/other fish intake was also associated with
omewhat higher prevalence of CHD and diabetes (possibly
ecause these individuals increased their fish intake after
heir diagnosis), but these associations were not statistically
ignificant. Estimated dietary intake of EPA  DHA from
hese fish meals is also shown.
Associations between tuna/other fish intake and ECG
arameters are shown in Table 2. After adjustment for
emographic variables, clinical risk factors, and lifestyle and
ietary characteristics, tuna/other fish consumption was
ssociated with a lower HR (p  0.001) and longer PR
able 1. Relationships Between Intake of Tuna or Other Broiled
Frequency of Intake
<1/Month
(n  545)
1–3/M
(n  1
ge, yrs 74  7 73 
ender, % male 47 47
ducation, %  high school 51 67
ody mass index, kg/m2 26  5 26 
iabetes mellitus, % 24 23
oronary heart disease, % 19 20
linical valvular disease, % 5 6
reated hypertension, %† 47 47
urrent smoking, % 15 14
moking history, pack-yrs 20  30 20 
eisure-time activity, kcal/week 1,590  2,106 1,786 
spirin use, % 19 22
eta-blocker use, % 13 14
ietary EPA  DHA, mg/day‡ 19  10 83 
alues are mean  SD or %. *p for trend 0.05; †use of antihypertensive medication
rom these fish meals based on estimated content of eicosapentaenoic acid (EPA) and
andings data (21).
able 2. Electrophysiologic Measures According to Intake of Tun
Frequency of Intake
<1/Month
(n  545)*
1–3/Mon
(n  1,20
eart rate, beats/min 66.0  0.1 65.7  0
trioventricular conduction (PR), ms 164.5  0.3 167.5  0
entricular conduction (QRS), ms 89.5  0.2 89.0  0
entricular conduction delay, % 7.6 8.6
rolonged QT (QTI 110), % 12.6 10.1
alues are mean  SE or percent, adjusted for age (years), gender (male/female), race
ormer, current), body mass index (kg/m2), diabetes mellitus (yes/no), coronary he
servings/day), fruits (servings/day), vegetables (servings/day), fried fish (3 categorie
ndividuals in whom the electrocardiogram measure was not available (between 1.3% t
undle branch block (QRS 120 ms; n  400) in analyses of ventricular conduction (QR
QTI  QT index.nterval (p  0.02). Comparing the highest and lowest
ategories of intake, the HR difference was 3.2 beats/min
95% confidence interval [CI]  1.3 to 5.1), and the PR
nterval difference was 7.2 ms (95% CI  1.4 to 12.9).
una/other fish intake was also associated with lower
ikelihood of prolonged QT (Table 2), with 50% lower
ikelihood in the highest category of intake, compared with
he lowest (relative risk [RR]  0.50, 95% CI  0.27 to
.95; p trend  0.03) (Fig. 1). Findings were similar for the
odified QTI (using JT index for individuals with QRS
120 ms): comparing the highest to the lowest category of
una/other fish intake, the relative risk was 0.51 (95% CI 
.28 to 0.93; p trend  0.06). Tuna/other fish intake was
ot associated with ventricular conduction time or likeli-
ood of ventricular conduction delay (Table 2). Fried fish
ntake was not associated with any of these ECG measures
not shown).
Because use of medications might be associated with fish
ntake and also affect cardiac ECG parameters, we repeated
he analyses separately adjusting for or excluding users of
elevant medications. The association between tuna/other
sh intake and HR was strengthened by exclusion of
articipants taking beta-blockers (n  656): comparing the
ighest and lowest categories of intake, the HR difference
aked Fish and Other Risk Factors Among 5,096 Older Adults
1–2/Week
(n  2,368)
3–4/Week
(n  762)
5/Week
(n  221)
73  5 72  5 72  5*
43 36 32*
76 83 77*
26  4 27  5 27  5*
22 22 28
19 19 28
6 6 9
44 44 49
10 10 7*
18  27 17  25 16  26*
6 1,874  2,100 1,891  2,032 1,680  1,840
21 22 25
12 14 17
262  129 474  0 1,070  444*
tics, angiotensin system agents, calcium-channel blockers, or beta-blockers); ‡intake
hexaenoic acid (DHA) in each serving (3 to 5 oz) (20) and U.S. fisheries commercial
Other Broiled or Baked Fish
1–2/Week
(n  2,368)*
3–4/Week
(n  762)*
5/Week
(n  221)* p Trend
64.8  0.1† 64.0  0.1‡ 62.7  0.2‡ 0.001
167.7  0.1 168.2  0.2 171.6  0.5† 0.03
88.8  0.1 89.2  0.1 89.2  0.3 0.60
6.6 6.8 6.2 0.15
9.8 8.9 6.8† 0.03
/non-white), education (high school, high school, high school), smoking (never,
ease (yes/no), leisure-time physical activity (kcal/day), and intakes of beef or pork
hol (drinks/week), and total calories (kcal/day). *Total number; for each outcome,
of participants) were not included in the analysis; we also excluded individuals withor B
onth
,200)
6
5
28
2,12
39
(diurea or
th
0)*
.1
.2
.1
(white
art dis
s), alco
o 5.9%S) or prolonged QT; †p  0.05, and ‡p  0.01 compared with intake 1/month.
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August 1, 2006:478–84 Fish Intake and ECG Parametersas 3.9 beats/min (95% CI  1.8 to 6.0; p trend 0.001).
dditional adjustment for or exclusion of participants tak-
ng beta-blockers, calcium-channel blockers, class 1A or
lass III antiarrhythmics, aspirin, or tricyclic antidepressants
id not appreciably alter these findings or results for the
ther ECG measures (data not shown).
Heart rate was inversely correlated with the PR interval
r  0.18, p  0.001) and QTc interval (r  0.22, p 
.001), the latter correlation indicating that effects of HR
re incompletely accounted for by Karjalainen QT interval
orrection. (In comparison, QTI was minimally correlated
ith HR: r  0.02.) Therefore, we evaluated the associa-
ions of tuna/other fish intake with the PR and QTc
ntervals after adjustment for HR to account for HR-related
ifferences in cardiac conduction and repolarization inter-
als. After adjustment for HR (other covariates per Table 2
ootnote), the association between tuna/other fish intake
nd the PR interval was partly attenuated (25%): compar-
ng the highest and lowest category of intake, the PR
nterval difference was 5.5 ms (95% CI  0.0 to 11.1). In
imilar analyses, tuna/other fish intake was associated
ith lower likelihood of prolonged QTc (440 ms):
ompared with intake 1/month, the adjusted relative
isks across categories of increasing tuna/other fish intake
ere 0.96, 0.80, 0.79, and 0.71 (p trend  0.048), or 29%
ower likelihood in the highest category of intake, com-
ared with the lowest. Tuna/other fish intake was not
ssociated with likelihood of shortened QTc (400 ms)
p trend  0.35).
In pre-specified subgroup analyses, the associations of
una/other fish intake with the ECG measures did not vary
ignificantly according to presence or absence of treated
ypertension or prevalent CHD (p interaction 0.05 for
ach). For example, after excluding individuals with preva-
ent CHD at baseline (n  997), tuna/other fish intake
comparing the highest to the lowest category of intake) was
till associated with lower HR (2.5 beats/min, 95% CI 
.4 to 4.7), slower atrioventricular conduction (PR interval
igure 1. The likelihood of prolonged QT (QT index [QTI] 110)
ccording to intake of tuna or other broiled or baked fish, after adjustment
or other risk factors (see Table 2 footnote).5.8 ms, 95% CI  0.6 to 12.1), and lower likelihood of irolonged QT (RR  0.50, 95% CI  0.24 to 1.06).
ender or racial-based differences were also not apparent
p interaction 0.05 for each). In a prior meta-analysis of
andomized controlled trials, fish oil supplementation had a
reater effect on HR among individuals with higher resting
R than among those with lower resting HR (14). A
imilar effect was seen in the current study with dietary fish
ntake (p interaction  0.01). Among individuals with HR
bove the median (65 beats/min), the HR was 2.7
eats/min lower (95% CI  0.2 to 5.2) in the highest
ategory of tuna/other fish intake, compared with the
owest. In contrast, among individuals with HR below the
edian (65 beats/min), the HR was only 0.4 beats/min
ower (95% CI  1.6 to 0.8) in the highest category of
una/other fish intake, compared with the lowest. Results
ere similar if participants taking beta-blockers were ex-
luded (not shown).
The associations between estimated dietary EPA  DHA
nd HR and prolonged QT were evaluated non-
arametrically (Fig. 2). For HR, a possible threshold effect
as seen, particularly after exclusion of participants taking
eta-blockers, with steeper decline in HR between intakes
f 0 and 300 mg/day, and then more gradual decline at
igher intakes (p threshold effect  0.066). For prolonged
T, a somewhat similar pattern was seen, although with
ess evidence for departure from a linear relationship
p threshold effects0.20). Evaluated continuously over the
ntire range, a 1 g/day higher EPA  DHA intake was
ssociated with 2.3 beats/min lower HR (95% CI  0.9 to
.7), 7.6 ms longer PR interval (95% CI 3.3 to 11.9), and
6% lower likelihood of prolonged QT (RR  0.54, 95%
I  0.33 to 0.88) (covariates per Table 2 footnote).
Fish intake may reduce systemic vascular resistance and
mprove blood pressure (13). To determine whether the
ssociations of fish intake with ECG characteristics could
artly be mediated by effects on these or other cardiac
arameters, we repeated the analyses further adjusting for
ystolic blood pressure, diastolic blood pressure, left ventric-
lar mass (29), and left ventricular systolic function (30)
other covariates per Table 2 footnote). Results were not
ppreciably altered: comparing extreme categories of tuna/
ther fish intake, HR was 3.3 beats/min lower (95% CI 
.3 to 5.2), PR interval was 8.5 ms longer (95% CI  2.8 to
4.3), and likelihood of prolonged QT was 53% lower (RR
0.47, 95% CI  0.24 to 0.91).
ISCUSSION
n this population-based cohort of more than 5,000 men
nd women, higher intake of tuna or other broiled or baked
sh was associated with several ECG parameters, including
ower HR, slower atrioventricular conduction (PR interval),
nd lower likelihood of abnormal ventricular repolarization
prolonged QT). Only 3 small prior studies (n  42, n 
3, n  74) have evaluated relations between fish or fish oil
ntake and these ECG-defined parameters in humans, with
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Fish Intake and ECG Parameters August 1, 2006:478–84enerally null results (31–33). To our knowledge, this is the
rst study to demonstrate in humans a relationship between
sual dietary intake of fish or marine n-3 fatty acids and
trioventricular conduction or ventricular repolarization.
R. The inverse association between tuna/other fish intake
nd HR is consistent with the HR reduction produced by fish
il supplementation in double-blind, placebo-controlled, ran-
omized trials (14). A dose-response effect was not seen at the
sh oil doses utilized in these trials (between1 and 15 g/day
PA  DHA) (14). Our present findings suggest that a
ose-response effect may exist at lower, dietary doses, with
raded reductions in HR as dietary consumption increases, at
east up to300 mg/day. (Table 2, Fig. 2). The association of
una/other fish intake with lower HRs was greater among
articipants with higher HR (2.7 beats/min with HR 65
s. 0.4 beats/min with HR 65; p interaction  0.01).
hese results are remarkably similar to the findings of the
andomized fish oil trials, in which HR was reduced to a
reater extent in populations with higher baseline HR (2.5
eats/min with HR69 vs.0.4 beats/min with HR69; p
nteraction  0.03) (14). These findings suggest that con-
umption of oily fish or fish oil may affect HR to a greater
igure 2. The association of dietary eicosapentaenoic acid (EPA) and
on-parametrically using restricted cubic splines and adjusted for other ris
resent at intake of 300 mg/day, particularly after exclusion of participa
ecline in heart rate with intakes between 0 and 300 mg/day, and then
lthough with less evidence for departure from a linear relationship (p thres
ertainty of associations at these high levels of intake. *The p value for th
ndex.xtent among individuals with higher resting HR, a group that say have increased sinus node automaticity, lower resting vagal
one, greater sympathetic tone, or lower ventricular efficiency.
trioventricular conduction and ventricular repolarization.
he demonstration of relationships, in humans, between fish
r marine n-3 fatty acid intake and atrioventricular conduction
i.e., PR interval) and ventricular repolarization (i.e., QT
nterval) is novel. These findings are consistent with animal-
xperimental studies showing effects of fish oil intake on the
R and QT intervals (7). The association of tuna/other fish
ntake with atrioventricular conduction was only partly
ttenuated by differences in HR, likely reflecting the only
odest correlation (r0.18) between these 2 parameters.
lowing of atrioventricular conduction could be due to
irect effects on atrioventricular nodal cells (e.g., via ion
hannel effects) or to effects on autonomic tone. Ventricular
epolarization is a complex process influenced by ion chan-
el function, intra- and extracellular ion concentrations,
lectrical coupling, and autonomic tone (34). Repolarization
s initially due to Na channel inactivation and transient K
fflux, followed by a balance of depolarizing L-type Ca2
urrents and repolarizing K currents, and then late K
fflux through delayed rectifier channels. In experimental
ahexaenoic acid (DHA) with heart rate and prolonged QT, evaluated
ors (see Table 2 footnote). For heart rate, a possible threshold effect was
king beta-blockers (n  656) (p threshold effect  0.066), with steeper
gradual decline. A somewhat similar pattern was seen for prolonged QT,
effects 0.20). Few subjects with intakes 1.5 g/day (n  24) limited the
tinuous association over the entire range. bpm  beats/min; QTI  QTdocos
k fact
nts ta
more
holdtudies, marine n-3 fatty acids inhibit the fast voltage-
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August 1, 2006:478–84 Fish Intake and ECG Parametersependent Na current and the L-type Ca2 current (6).
hese in-vitro effects could, at least in part, explain the
ower risk of prolonged repolarization seen with tuna/other
sh intake in the present study. Djousse et al. (35) recently
eported that intake of alpha-linolenic acid, a plant-derived
-3 fatty acid, was associated with lower risk of prolonged
T. Our findings suggest that dietary intake of oily fish and
arine n-3 fatty acids may also lower the risk of QT
rolongation.
otential clinical implications. A higher resting HR is
ssociated with increased risk of sudden death (8,9,36–38).
his may reflect greater myocardial vulnerability to ischemia
r arrhythmia, or lower underlying cardiovascular health as
anifested by increased sympathetic tone, decreased vagal
one, or decreased ventricular efficiency. Based on Jouven
t al. (9), our finding of a 3.2 beats/min lower HR with
igher tuna/other fish consumption would correspond to
7.5% lower risk of sudden death. The relevance of
trioventricular conduction time to arrhythmic risk has not
een established. However, a prolonged QT interval is
ssociated with a higher risk of sudden death (10–12).
mong individuals without left ventricular systolic dysfunc-
ion, those with a normal QT interval had a 57% lower risk
f sudden death, compared with those with a prolonged QT
nterval (10). Thus, although other mechanisms may also
ontribute to reductions in clinical risk, the observed differ-
nces in HR and ventricular repolarization may, in part,
ccount for the lower incidence of arrhythmic events seen
ith fish and fish oil intake.
roarrhythmia versus antiarrhythmia. In a randomized
rial among patients with implantable defibrillators (n 
00), fish oil supplementation increased the risk of re-
ntrant ventricular tachycardia in a subset of patients (39).
n contrast, in a second similar trial (n  402), fish oil
upplementation decreased the risk of ventricular fibrillation
r tachycardia (40). In a large trial of fish oil supplementa-
ion among patients with recent myocardial infarction (n 
1,324), fish oil supplementation reduced sudden death by
55% (41). It is well recognized that drugs that affect
entricular conduction or repolarization can be both anti-
nd proarrhythmic (42). An effect of fish oil on ventricular
epolarization, as suggested by our findings, could lower risk
f ventricular fibrillation in most individuals, particularly in
he setting of acute ischemia, but also possibly increase risk
f re-entrant tachycardia in a small and specific subset of
ndividuals with a slow re-entrant arrhythmic loop around a
egion of scarred myocardium.
tudy limitations. Although the diet questionnaire as-
essed usual dietary intake in the year before the ECG, a
ross-sectional analysis cannot establish temporality. Fish
onsumption among some older individuals may be partially
riven by lifestyle changes in response to chronic disease
evelopment and physician guidance; consistent with this,
ndividuals with the highest tuna/other fish consumption
ere slightly more likely to have CHD, diabetes, or valvular
isease and to use aspirin and beta-blockers (Table 1).ecause these individuals would be more likely to have abnor-
al cardiac electrophysiology, this would drive the observed
eneficial associations toward the null. These associations were
bserved in older, predominantly white individuals partici-
ating in a cohort study and may not be generalizable to
ther populations. More detailed information on fish spe-
ies consumed or other preparation methods was not avail-
ble. While a range of covariates were available in the CHS
nd were evaluated as potential confounders, residual con-
ounding due to unknown or incompletely measured factors
annot be excluded. On the other hand, the consistency
ith results of animal-experimental studies and short-
erm trials of fish oil supplementation in humans make it
nlikely that residual confounding entirely accounts for our
ndings. The assessments of both fish and n-3 fatty acid
ntake and the ECG parameters were subject to both
andom error and biologic variability, which would produce
ias toward the null and result in underestimation of the
agnitude of the associations.
onclusions. Our results suggest that consumption of fish
nd marine n-3 fatty acids is associated with cardiac
lectrophysiology in humans, including HR, atrioventricular
onduction, and ventricular repolarization. Additional stud-
es are warranted to confirm these findings, and cellular
echanisms and implications for arrhythmic risk deserve
urther investigation.
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